News

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.
Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to ...
IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...
Xilio anticipates nominating a development candidate for its PSMA program in the ATACR format in the third quarter of 2025 ...
Researchers at Linköping University have developed a new type of pipette that can deliver ions to individual neurons without ...
Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.
When Treg cells are produced, they are trained to recognize specific peptides, including self-peptides from the body. When ...
Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...
Researchers at Linköping University, Sweden, have developed a new type of pipette that can deliver ions to individual neurons ...
A key enzyme and its molecular pathway are critical to keeping certain immune cells active and away from "exhaustion," ...